SECsense Logo

Immuron Limited's 2025 Financial Report: Research Collaboration & Securities Update

$IMRN
Form 6-K
Filed on: 2025-01-15
Source
Immuron Limited's 2025 Financial Report: Research Collaboration & Securities Update

Here are the key insights extracted from the financial report of Immuron Limited:

  1. Filing Details:
  • Document Type: Form 6-K
  • Filing Date: January 15, 2025
  • Commission File Number: 001-38104
  1. Company Information:
  • Registrant Name: Immuron Limited
  • Address: Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia
  1. Content of the Report:
  • The report includes two announcements made by Immuron Limited to the Australian Securities Exchange on January 15, 2025:
    • Announcement 1: "Immuron Announces Monash AMR Research Collaboration"
    • Announcement 2: "Proposed issue of securities – IMC"
  • A copy of these public notices is attached as an exhibit to the report.
  1. Filing Status:
  • The report is filed under the requirements of the Securities Exchange Act of 1934 but is not considered “filed” for the purposes of the Act and will not be incorporated by reference into any filing under the Securities Act of 1933, unless expressly referenced.
  1. Exhibits:
  • Exhibit 99.1: Details about the research collaboration with Monash University regarding AMR (Antimicrobial Resistance).
  • Exhibit 99.2: Information regarding the proposed issue of securities related to IMC (presumably related to the company's investment or financing strategies).
  1. Signatory Information:
  • The report is signed by Phillip Hains, who holds the position of Company Secretary.

This report indicates that Immuron Limited is actively engaging in research collaborations and possibly seeking to raise capital or issue securities, which could be significant for its business strategy moving forward.